Since 30 April ECDC has been working on a number of documents related to the influenza A(H1N1) pandemic. As well as daily Situation Reports and regular surveillance reports the following have been published or updated:

ECDC Interim Risk Assessment: Pandemic (H1N1) 2009 influenza

ECDC has released an updated risk assessment of the pandemic influenza A(H1N1) 2009. The document points out that the virus will continue to transmit in a heterogeneous manner but at a low level over the summer in European countries and that it is likely that a proper first wave of the pandemic will take place in the autumn and winter.

Possible target readership: public health officials, influenza experts, policymakers, general public
Read more

ECDC Health Education: On public health use of influenza antivirals during influenza pandemics (with particular reference to the pandemic (H1N1) 2009)

This document gives a short, four-page overview on the use of pandemic vaccines. It includes specific information on the nature of antivirals, their effectiveness, and their side effects. Further topics include priorities for antiviral use and the stockpiling of antivirals in some countries.

Possible target readership: public health officials, influenza experts, policymakers, general public
Read more

ECDC Health Education: On the use of specific pandemic influenza vaccines

This document gives a short, three-page overview on the use of pandemic vaccines. It includes specific information on the importance of vaccination, priority groups for vaccination, and the monitoring and evaluation of the vaccination programme.

Possible target readership: public health officials, influenza experts, policymakers, general public
Read more (the ECDC web sight /Related documents)

Annual Report of the Director: Summary 2008

Since its establishment in 2005, the European Centre for Disease Prevention and Control (ECDC) has experienced dynamic growth. In 2008, the Centre reached a phase of both consolidation and continuing expansion, and is now well on its way to becoming a ‘centre of excellence’ in the fight against infectious diseases in Europe, as well as a prime source of information for the scientific community.

Possible target readership: general public, policymakers, stakeholders.
Read more

Interim guidance: Use of specific pandemic influenza vaccines during the H1N1 2009 pandemic

This interim guidance outlines the possible strategies that countries may wish to adopt in the deployment of a pandemic-specific vaccine, considering the two objectives of vaccination: protecting those at greatest risk of severe disease and maintaining essential services.

The guidance is based on the experience of the current H1N1 pandemic to date. As the situation evolves, the guidance may be updated to reflect new developments.

Possible target readership: public health officials, policymakers, clinicians
Read more

Surveillance and studies in a pandemic: Fourth meeting of the SSiaP working group

The working group for Surveillance studies in a pandemic (SSiaP) met for the fourth time on 14–15 July 2009, in Stockholm. The final report of that meeting presents the outcomes of the discussions on addressing the challenges for surveillance during a pandemic.

Topics include experiences with the H1N1 pandemic in several countries, technical and scientific aspects of monitoring in a pandemic, and an agreement on the minimum scope of surveillance tasks that EU Member States can reasonably deliver in an epidemic of the magnitude of the current H1N1 pandemic.

Possible target readership: public health officials, influenza experts, surveillance experts, policymakers
Read more

ECDC Insight – September 2009 issue

This eight page quarterly newsletter keeps you up to date with what is going on in ECDC. It contains news and features about the work of ECDC. It also introduces you to some people involved both in ECDC and in our partner organisations.

Possible target readership: General public, ECDC stakeholders.
Read more

ECDC Executive Science Update – July-September 2009 issue

This two page quarterly bulletin gives you a rapid briefing on key scientific outputs from ECDC – and their potential implications for policy makers. The December issue of ECDC’s Executive Science Update features articles on an outbreak of Q-fever in the Netherlands in 2008 and a review of latest developments on variant-CJD.

Possible target readership: Policy makers, other ECDC stakeholders
Read more